Aura Biosciences(Aura Biosciences, Inc.)通过实施组织重组与资本配置策略,显著延长了其现金储备的可持续性,现预期可支撑公司运营至2029年上半年。
Aura Biosciences(Aura Biosciences, Inc.)通过实施组织重组与资本配置策略,显著延长了其现金储备的可持续性,现预期可支撑公司运营至2029年上半年。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.